Non-erythroid alpha spectrin (αIISp) is a structural protein which we have shown is present in the nucleus of human cells. It interacts with a number of nuclear proteins such as actin, lamin, emerin, chromatin remodeling factors, and DNA repair proteins. αIISp’s interaction with DNA repair proteins has been extensively studied. We have demonstrated that nuclear αIISp is critical in DNA interstrand cross-link (ICL) repair in S phase, in both genomic (non-telomeric) and telomeric DNA, and in maintenance of genomic stability following ICL damage to DNA. We have proposed that αIISp acts as a scaffold aiding to recruit repair proteins to sites of damage. This involvement of αIISp in ICL repair and telomere maintenance after ICL damage represents new and critical functions for αIISp. These studies have led to development of a model for the role of αIISp in DNA ICL repair. They have been aided by examination of cells from patients with Fanconi anemia (FA), a repair-deficient genetic disorder in which a deficiency in αIISp leads to defective ICL repair in genomic and telomeric DNA, telomere dysfunction, and chromosome instability following DNA ICL damage. We have shown that loss of αIISp in FA cells is due to increased breakdown by the protease, µ-calpain. Importantly, we have demonstrated that this deficiency can be corrected by knockdown of µ-calpain and restoring αIISp levels to normal. This corrects a number of the phenotypic deficiencies in FA after ICL damage. These studies suggest a new and unexplored direction for therapeutically restoring genomic stability in FA cells and for correcting numerous phenotypic deficiencies occurring after ICL damage. Developing a more in-depth understanding of the importance of the interaction of αIISp with other nuclear proteins could significantly enhance our knowledge of the consequences of loss of αIISp on critical nuclear processes.
GoodmanSRZagonISKulikowskiRR. Identification of a spectrin-like protein in nonerythroid cells. Proc Natl Acad Sci USA1981; 78: 7570–4.
8.
MachnickaBGrochowalskaRBoguslawskaDMSikorskiAFLecomteMC. Spectrin-based skeleton as an actor in cell signaling. Cell Mol Life Sci2012; 69: 191–201.
9.
ZagonISHigbeeRRiedererBMGoodmanSR. Spectrin subtypes in mammalian brain: an immunoelectron microscopic study. J Neurosci1986; 6: 2977–66.
10.
GascardPMohandasN. New insights into functions of erythroid proteins in nonerythroid cells. Curr Opin Hematol2000; 7: 123–9.
11.
MetralSMachnickaBBigotSColinYDhermyDLecomteM-C. αII-Spectrin is critical for cell adhesion and cell cycle. J Biol Chem2009; 284: 2409–18.
12.
StankewichMCCianciCDStabachPRJiLNathAMorrowJ. Cell organization, growth, and neural and cardiac development require αII-spectrin. J Cell Sci2011; 124: 3956–66.
13.
BroisDWMcMahonLWRamosNIAnglinLMWalshCELambertMW. A deficiency in a 230 kDa DNA repair protein in Fanconi anemia complementation group A cells is corrected by the FANCA cDNA. Carcinogenesis1999; 20: 1845–53.
14.
McMahonLWWalshCELambertMW. Human α spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex. J Biol Chem1999; 274: 32904–8.
McMahonLWSangermanJGoodmanSRKumaresanKLambertMW. Human alpha spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links. Biochemistry2001; 40: 7025–34.
17.
SridharanDBrownMLambertWCMcMahonLWLambertMW. Nonerythroid alpha II spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links. J Cell Sci2003; 116: 823–5.
18.
McMahonLWZhangPSridharanDMLeffertsJALambertMW. Knockdown of αII spectrin in normal human cells by siRNA leads to chromosomal instability and decreased DNA interstrand cross-link repair. Biochem Biophys Res Commun2009; 381: 288–93.
19.
ZhangPSridharanDLambertMW. Knockdown of µ-calpain in Fanconi anemia, FA-A, cells by siRNA restores αII spectrin levels and corrects chromosomal instability and defective DNA interstrand cross-link repair. Biochemistry2010; 49: 5570–81.
20.
ZhangPHerbigUCoffmanFLambertMW. Non-erythroid alpha spectrin prevents telomere dysfunction after DNA interstrand cross-link damage. Nucleic Acids Res2013; 41: 5321–40.
21.
KumaresanKSridharanDMcMahonLLambertMW. Deficiency in incisions produced by XPF at the site of a DNA interstrand cross-link in Fanconi anemia cells. Biochemistry2007; 46: 14359–68.
22.
SridharanDMMcMahonLWLambertMW. αII-Spectrin interacts with five groups of functionally important proteins in the nucleus. Cell Biol Int2006; 30: 866–78.
23.
JoenjeHPatelKJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet2001; 2: 446–57.
MathewCG. Fanconi anaemia genes and susceptibility to cancer. Oncogene2006; 25: 5875–84.
26.
de WinterJPJoenjeH. The genetic and molecular basis of Fanconi anemia. Mutat Res Fundam Mol Mech Mutagen2009; 668: 11–9.
27.
MoldovanG-LD’AndreaA. How the Fanconi anemia pathway guards the genome. Rev Genet Ann2009; 43: 223–49.
28.
KottemannMCSmogorzewskaA. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature2013; 493: 356–63.
29.
KimHD’AndreaAD. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev2012; 26: 1393–408.
30.
LambertMWTsongalisJTLambertWCParrishDD. Correction of the DNA repair defect in Fanconi anemia complementation groups A and D cells. Biochem Biophys Res Commun1997; 230: 687–91.
31.
KumaresanKRLambertMW. Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links. Carcinogenesis2000; 21: 741–51.
32.
AkkariYMBatemanRReifsteckCAOlsonSBGrompeM. DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links. Mol Cell Biol2000; 20: 8283–9.
33.
RaschleMKnipsheerPEnoiuMAngelovTSunJGriffithJDEllenbergerTEScharerODWalterJC. Mechanism of replication-coupled DNA interstrand crosslink repair. Cell2008; 134: 969–80.
34.
KnipscheerPRaschleMSmogorzewskaAEnoiuMHoTVScharerODElledgeSJWalterJC. The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science2009; 326: 1698–701.
35.
LegerskiRJ. Repair of DNA interstrand cross-links during S phase of the mammalian cell cycle. Environ Mol Mutagen2010; 51: 540–51.
36.
DuxinPDWalterJC. What is the DNA repair defect underlying Fanconi anemia?Curr Opin Cell Biol2015; 37: 49–60.
37.
LeeJCoyneRSDubreuilRRGoldsteinLSBrantonD. Cell shape and interaction defects in alpha-spectrin mutants of Drosophila melanogaster. J Cell Biol1993; 123: 1797–809.
38.
NormanKRMoermanDG. αSpectrin is essential for morphogenesis and body wall muscle formation in Caenorhabditis elegans. J Cell Biol2002; 157: 665–77.
39.
KumaresanKRHangBLambertMW. Human endonucleolytic incision of DNA 3′ and 5′ to a site-directed psoralen monoadduct and interstrand cross-link. J Biol Chem1995; 270: 30709–16.
40.
Klein DouwelDBoonRACMLongDTSzypowskaAARaschleMWalterJCKnipscheerP. XPF-ERCC1 acts in unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4. Mol Cell2014; 54: 460–71.
41.
WangW. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet2007; 8: 735–48.
42.
SekiSOhzekiMUchiadaAHiranoSMatsushitaNKitaoHOdaTYamashitaTKashiharaNTsubaharaATakataMIshiaiM. A requirement of FancL and FancD2 monoubiquitination in DNA repair. Genes Cells2007; 12: 299–310.
43.
WaldenHDeansAJ. The Fanconi anemia DNA repair pathway: structural and functional insights into a complex disorder. Ann Rev Biophys2014; 43: 257–78.
44.
ZhangPSridharanDLambertMW. Nuclear α spectrin differentially affects monoubiquitinated versus non-ubiquitinated FANCD2 function after DNA interstrand cross-link damage. J Cell Biochem2016; 117: 671–83.
45.
LeffertsJAWangCSridharanDBaraltMLambertMW. The SH3 domain of αII spectrin is a target for the Fanconi anemia protein, FANCG. Biochemistry2009; 48: 254–63.
46.
WangCLambertMW. The Fanconi anemia protein, FANCG, binds to the ERCC1-XPF endonuclease via its tetratricopeptide repeats and the central domain of ERCC1. Biochemistry2010; 49: 5560–9.
47.
ZhangJWalterJC. Mechanism and regulation of incisions during DNA interstrand cross-link repair. DNA Repair2014; 19: 135–42.
48.
BhagwatNOlsenALWangATHanadaKStuckertPKanaarRD'AndreaANiedernhoferLJMcHughPJ. XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair. Mol Cell Biol2009; 29: 6427–37.
49.
Ziemnicka-KotulaDXuJGuiHPotempskaAKimKSJenkinsECTrenknerEKotulaL. Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton. J Biol Chem1998; 273: 13681–92.
50.
KuriyanJCowburnD. Modular peptide recognition domains in eukaryotic signaling. Annu Rev Biophys Biomol Struct1997; 26: 259–88.
51.
SteinR. SH2 and SH3 domains. Unraveling signaling networks with peptide antogonists. Methods Mol Biol1998; 88: 187–95.
52.
McPhersonPS. Regulatory role of SH3 domain-mediated protein-protein interactions in synaptic vesicle endocytosis. Cell Signal1999; 11: 229–38.
RenRMayerBJCicchettiPBaltimoreD. Identification of a ten-amino acid proline-rich SH3 binding site. Science1993; 259: 1157–61.
55.
FenSChenJKYuHSimonJASchreiberSL. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science1994; 266: 1241–7.
56.
LimWARichardsFMFoxRO. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature1994; 372: 375–9.
57.
KayBKWilliamsonMPSudolM. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J2000; 14: 231–41.
58.
CesareniGPanniSNardelliGCastagnoliL. Can we infer peptide recognition specificity mediated by SH3 domains?FEBS Lett2002; 513: 38–44.
59.
BlatchGLLassleM. The tetratricopeptide repeat: a structural motif mediating protein–protein interactions. Bioessays1999; 21: 932–9.
BlomEvan de VrugtHJde VriesYde WinterJPArwertFJoenjeH. Multiple TPR motifs characterize the Fanconi anaemia FANCG protein. DNA Repair2004; 3: 77–84.
62.
HussainSWilsonJBBlomWThompsonLHSungPGordonSMKupferGMJoenjeHMathewCGJonesNJ. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2. DNA Repair2006; 5: 629–40.
63.
de LaatWLSijbersAMOdijkHJaspersNGHoeijmakersJH. Mapping of interaction domains between human repair proteins ERCC1 and XPF. Nucl Acids Res1998; 26: 4146–5.
64.
TripsianesKFolkersGEAbEDasDOdijkHJaspersNGJHoeijmakersJHJKaptenRBoelensR. The structure of the human ERCC1/XPF interaction domains reveals a complementary role for the two proteins in nucleotide excision repair. Structure2005; 13: 1849–58.
65.
ChoiYJRyuKSKoYMChaeYKPletonJGWemmerDEChoiBS. Biophysical characterization of the interaction domains and mapping of the contact residues in the XPF-ERCC1 complex. J Biol Chem2005; 280: 28644–52.
66.
de LangeT. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev2005; 19: 2100–10.
67.
MurnaneJP. Telomere dysfunction and chromosome instability. Mutat Res2012; 730: 28–36.
68.
PalmWde LangeT. How shelterin protects mammalian telomeres. Annu Rev Genet2008; 42: 301–34.
SfeirAde LangeT. Removal of shelterin reveals the telomere end-protection problem. Science2012; 336: 593–7.
71.
SmogorzewskaAde LangeT. Regulation of telomerase by telomeric proteins. Annu Rev Biochem2004; 73: 177–208.
72.
BlackburnEH. Telomeres and telomerase. FEBS Lett2005; 579: 859–62.
73.
KimHLeeO-HXinHChenL-YQinJChaeHKLinS-YSafariALiuDSongyangZ. TRF2 functions as a protein hub and regulates telomere maintenance by recognizing specific peptide motifs. Nat Struct Mol Biol2009; 16: 372–9.
74.
DiottiRLoayzaD. Shelterin complex and associated factors at human telomeres. Nucleus2011; 2: 119–35.
75.
WrightWETesmerVMLiaoMLShayJW. Normal human telomeres are not late replicating. Exp Cell Res1999; 251: 492–9.
76.
TakaiHSmogorzewskaAde LangeT. DNA damage foci at dysfunctional telomeres. Curr Biol2003; 13: 1549–56.
77.
CechTR. Beginning to understand the end of the chromosome. Cell2004; 116: 272–9.
78.
KimNWPiatyszekMAProwseKRHarleyCBWestMDHoPLCocielloGMWrightWEWeinrichSLShayJW. Specific association of human telomerase activity with immortal cells and cancer. Science1994; 266: 2011–5.
79.
BroccoliDYoungJWde LangeT. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA1995; 92: 9082–6.
80.
FanQZhangFBarrettBRenKAndreassenPR. A role for monoubiquitinated FANCD2 at telomeres in ALT cells. Nucleic Acids Res2009; 37: 1740–54.
81.
Dong H, Nebert DW, Bruford EA, Thompson DC, Joenje H, Vasiliou V. Update of the human and mouse Fanconi anemia genes. Hum Genet 2015;99:32–42.
82.
LeffertsJALambertMW. Fanconi anemia cell lines deficient in αII spectrin express normal levels of αII spectrin mRNA. Biochem Biophys Res Commun2003; 307: 510–5.
83.
Garcia-HigueraITaniguchiTGanesanSMeynMSTimmersCHejnaJGrompeMd’AndreaAD. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell2001; 7: 249–62.
84.
KachnicLALiLFournierLWillersH. Fanconi anemia pathway revealed by cisplatin and oxaliplatin treatments. Cancer Lett2010; 292: 73–9.
85.
WilsonJBYamamotoKMarriottASHussainSSungPHoatlinMEMathewCGTakataMThompsonLHKupferGMJonesNJ. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3. Oncogene2008; 27: 3641–52.
86.
WilsonJBBlomECunninghamRXiaoYKupferGMJonesNJ. Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance. Mutat Res2010; 689: 12–20.
87.
HussainSWilsonJBBlomWThompsonLHSungPGordonSMKupferGMJoenjeHMathewCGJonesNJ. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2. DNA Repair2006; 5: 629–40.
88.
RaghunandanMChaudhuryIKellichSLHanenbergHSoebeckA. FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi anemia complex. Cell Cycle2015; 143: 342–53.
89.
NicolasGFournierCMGalandCMalbert-ColasLBournierOKroviarskiYBourgeoisMCamonisJHDhermyDGrandchampBLecomteMC. Tyrosine phosphorylation regulates alpha II spectrin cleavage by calpain. Mol Cell Biol2002; 22: 3527–36.
HarrisASCroallDEMorrowJS. Calmodulin regulates fodrin susceptibility to cleavage by calcium-dependent protease I. J Biol Chem1989; 264: 17401–8.
92.
GormanEBChenLAlbaneseJRatechH. Pattern of spectrin expression in B-cell lymphomas: loss of spectrin isoforms is associated with nodule-forming and germinal center-related lymphomas. Mod Pathol2007; 20: 1245–52.
93.
WolqustLPCannizzarroLARameshjkHXueXWangDBhattacharuyaPKGongJZMcMahonCAlbaneseJMSunkaraJLRatechH. Differential expression in normal hematopoiesis and alterations in neoplastic bone marrow disorders. Am J Clin Pathol2011; 136: 300–8.
94.
AlterBP. Cancer in Fanconi anemia, 1927–2001. Cancer2003; 97: 425–40.
95.
GollDEThompsonVFKiHWeiWCongJ. The calpain system. Physiol Rev2003; 83: 731–801.
96.
RiedererBMZagonISGoodmanSR. Brain spectrin(240/235) and brain spectrin(240/235E): differential expression during mouse brain development. J Neurosci1987; 7: 864–74.
97.
ZagonISRidererBMGoodmanSR. Spectrin expression during mammalian brain ontogeny. Brain Res Bull1987; 18: 799–807.
LiuYBallmanKLiDKhanSDerr-YellinEShouWHanelineLS. Impaired function of Fanconi anemia type C-deficient macrophages. J Leukocyte Biol2012; 91: 333–40.
100.
HolaskaJMWilsonKL. An emerin ‘proteome’: purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechano-sensing and nuclear architecture. Biochem2007; 46: 8897–908.
101.
Silverman-GavrilaRVSolverman-GavrilaLBBilalKHBendeckMP. Spectrin alpha is important for rear polarization of the microtubule organizing center during migration and spindle pole assembly during division of neointimal smooth muscle cells. Cytoskeleton2015; 72: 157–70.
102.
KannM-LFouquetJP. Association of spectrin with manchette microtubules in mammalian spermatids. Biol Cell1993; 7: 311–13.
103.
Rieder BM, Goodman SR. Association of brain spectrin isoforms with microtubules. FEBS Lett 2001;277:49–51.
104.
ChangTLCubillosFFKakhniashviliDGGoodmanSR. Ankyrin is a target of spectrin’s E2/E3 ubiquitin-conjugating/ligating activity. Cell Mol Biol2004; 50: 59–66.
